or
forgot password

Impact of C-arm CT in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transhepatic Arterial Chemoembolization (TACE): Optimal Imaging Guidance


N/A
18 Years
N/A
Not Enrolling
Both
Carcinoma, Hepatocellular

Thank you

Trial Information

Impact of C-arm CT in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transhepatic Arterial Chemoembolization (TACE): Optimal Imaging Guidance


Inclusion Criteria:



Patients must be affected by HCC

Patients must be 18 years old or older

Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to the
TACE procedure.

Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

Subjects under the age of 18

Pregnant women

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

To determine if the increased radiation dose from CACT is outweighed by the increased information it provides, leading to lower total radiation dose required for catheter positioning.

Outcome Time Frame:

unknown

Safety Issue:

Yes

Principal Investigator

Dr. Rebecca Fahrig

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

SU-05122009-2518

NCT ID:

NCT00926536

Start Date:

April 2009

Completion Date:

March 2010

Related Keywords:

  • Carcinoma, Hepatocellular
  • Carcinoma
  • Carcinoma, Hepatocellular

Name

Location
Stanford University School of Medicine Stanford, California  94305-5317